ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
October 28, 2021 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 20%, operating profit up 21%, non-GAAP operating profit up 18% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at...
ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
October 07, 2021 16:05 ET
|
ResMed Inc.
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2022 on Thursday,...
ResMed Announces Participation in the Bank of America Global Healthcare Conference
September 08, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank...
People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS
September 08, 2021 06:45 ET
|
ResMed Inc.
LYON, France, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Using PAP (positive airway pressure) therapy as directed can significantly increase sleep apnea patients’ chances of living longer, according to a...
ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
September 02, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley...
ResMed Announces SaaS Leadership Change
August 25, 2021 16:15 ET
|
ResMed Inc.
SAN DIEGO, Aug. 25, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), today announced the promotion of Bobby Ghoshal to President of ResMed’s SaaS business, effective immediately. Raj Sodhi...
ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
August 16, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021
August 05, 2021 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 14%, operating profit up 8%, non-GAAP operating profit up 7%Quarterly dividend increases 8% to $0.42 per shareCompany to host a virtual Investor Day on September 8, 2021,...
ResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021
July 15, 2021 16:05 ET
|
ResMed Inc.
SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2021 on...
ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference
June 02, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the...